HIV

Non-EU and EEA countries trail behind in reaching viral suppression target by 2020.

In a study published in Nature Medicine, investigators found that when a virus enters the bloodstream it activates the first responder immune cells, CX3CR1highLY6Clow monocytes.

Virus-driven immune activation blocks connections between nerve cells in the brain.

The criminalization of drug use could be detrimental to HIV patient health and does not decrease use, study suggests.

T cells trained to attack Epstein Barr virus may be an effective treatment against multiple sclerosis.

Patients with HIV have nearly twice the risk of ischemic heart disease, heart failure, and myocardial infection.

As patients with HIV age, they develop chronic conditions associated with older age and take more medication.

Until recently, polypharmacy was not a tremendous concern among individuals with HIV.

Investing in diagnostic resources, prevention, and treatment programs are vital to ending the HIV epidemic in the United States.

Top news of the day from across the health care landscape.

Hepatitis C virus infection rates are the highest in 15 years, according to recent data released by the CDC.

Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses how specialty pharmacists can help patients manage adverse events from their treatment regimen.

Top articles of the week on Specialty Pharmacy Times.

HIV has become a chronic disease that requires a different strategy with aging patients.

Data discusses the unique issues senior patients with HIV face.

The shifting landscape in specialty dispensing among pharmacies that service patients in senior care settings and long-term care facilities.

Many patients with HIV who were on the leading edge of treatment advances are now in their 50s and 60s.

The study is the first to demonstrate that CRISPR/Cas9 technology may lead to an HIV cure.

Patients with HIV on ART may have high viral levels, immune activation, and inflammation.

Study provides visualization of different conformations of transporter in motion that may lead to more effective anticancer and antiviral drugs.

Opioid epidemic fuels hepatitis C transmission.

The risk of comorbid chronic obstructive pulmonary disorder in patients infected with HIV may be underestimated.

The transition to value-based reimbursement is likely to shape the future of health care.

Study provides first direct evidence of HIV persistence in tissue macrophages in vivo, which could lead to a cure for HIV.

Pitavastatin reduced LDL cholesterol with little impact on HIV-1 RNA and CD4 cell counts.